Carnosine
Also known as: beta-alanyl-L-histidine, Carnosine, Ignotine, L-Carnosine, N-beta-alanyl-L-histidine, N‑acetylcarnosine, β‑alanine‑L‑histidine
Source Carnosine at Peptiology
Save 10% with code PEPTI-BOSSRABBIT-10
Affiliate link: we earn a commission on purchases made through this link, at no extra cost to you.
Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.
Summary
Carnosine (β‑alanine‑L‑histidine) is a naturally occurring dipeptide found in skeletal muscle and brain tissue. It can be taken orally or applied topically as a supplement. In humans it is synthesized from the essential amino acid histidine and the non‑essential β‑alanine, and is studied for its intracellular buffering, antioxidant, anti‑glycation and metal‑chelating properties, as well as for potential benefits in exercise performance and various health conditions.
Mechanism of Action
Carnosine is produced in cells by carnosine synthase, which joins β‑alanine and histidine using ATP. The imidazole ring of the histidine residue provides pH‑buffering capacity, while the dipeptide can chelate transition metals and scavenge reactive oxygen species, reducing oxidative stress. It also interferes with formation of advanced glycation and lipoxidation end‑products, contributing to anti‑glycation effects. β‑Alanine availability limits synthesis, making dietary β‑alanine supplementation a common strategy to raise tissue carnosine levels.
What the Research Shows
Systematic reviews of β‑alanine supplementation, the primary precursor of carnosine, show a modest overall improvement in exercise capacity (effect size 0.18) with greater benefits for short‑duration (0.5‑10 min) tasks and when combined with sodium bicarbonate (effect size 0.43). Position statements report that 4‑6 g daily for 4 weeks raises muscle carnosine and improves performance, with paraesthesia as the main side effect. Narrative reviews suggest potential benefits of carnosine or its derivatives in sarcopenia, cognitive decline, diabetes, oral mucositis, gastrointestinal protection and Helicobacter pylori treatment, though evidence is mixed for cataracts, cardiovascular disease, schizophrenia and autism. An autism network meta‑analysis noted low‑confidence signals of benefit from carnosine supplementation.
Reported Benefits
Evidence supports that raising muscle carnosine via β‑alanine supplementation can enhance intracellular pH buffering, leading to modest gains in short‑duration exercise performance and reduced neuromuscular fatigue. Preliminary clinical data suggest carnosine may help prevent age‑related muscle loss, support cognitive function, improve glycemic control in diabetes, protect gastrointestinal mucosa, and alleviate oral mucositis, with anti‑inflammatory and antioxidant actions contributing to these effects.
Limitations of the Evidence
Many health‑related claims for carnosine rely on pre‑clinical studies or small, short‑term clinical trials, resulting in low to moderate confidence. Benefits for cataracts, cardiovascular disease, schizophrenia and autism remain inconclusive. The magnitude of performance enhancement is modest, and individual responses vary. More large, well‑controlled studies are needed to confirm therapeutic potential beyond exercise.
Safety Considerations
β‑Alanine supplementation, the common method to increase carnosine, is generally regarded as safe for healthy adults at 4‑6 g per day. The principal adverse effect is transient paraesthesia (tingling), which can be reduced by splitting doses (e.g., 1.6 g) or using sustained‑release formulations. No serious adverse events have been reported in the cited literature, but long‑term safety of high‑dose carnosine itself has not been established.
How It Is Administered
Carnosine can be taken orally, often as β‑alanine powder or capsules, with typical protocols using 4‑6 g of β‑alanine daily for at least 4 weeks to elevate muscle carnosine. Dividing the dose throughout the day or using sustained‑release products helps minimize paraesthesia. Topical formulations exist for skin applications, but specific dosing details are not provided in the cited sources.
Routes of Administration
Goals & Uses
- Exercise performance and muscle bufferingAthletic PerformanceModerate
- Anti‑glycationAgingLow
- NeuroprotectionNeurologyLow
- Metabolic syndrome / glycemic controlMetabolic HealthModerate
- Wound healing and skin anti-agingDermatologyLow
- Ocular health (cataracts)OphthalmologyLow
- Antioxidant supportOxidative StressModerate
- pH buffering in muscleExercise PerformanceModerate
- Anti-aging / cellular protectionLongevityLow
Contraindications
- Severe renal impairmentOrganModerateKidney function concerns
- Known hypersensitivity to carnosine or beta-alanineAllergyHigh
- Carnosinemia (carnosinase deficiency)Metabolic DisorderHigh
Adverse Effects
- Gastrointestinal discomfortGastrointestinalUncommon
- Neurological effects in carnosinemiaNeurologicalRare
- Paresthesia / tinglingNeurologicalUncommon
- Hypotension (intravenous)CardiovascularRare
Drug Interactions
- Zinc supplements / zinc-containing compoundsLow
- Antidiabetic agentsLow
- ACE inhibitorsLow
Population Constraints
- Renal impairmentOrgan ImpairmentRelative
- Pediatric populationsAgeRelative
- Pregnant or lactating womenReproductiveRelative
- Pregnancy and lactationReproductiveRelative
Regulatory Status
- European UnionUnapprovedMarketed as a food supplement; no medicinal approval.
- United StatesUnapprovedAvailable as a dietary supplement; not FDA‑approved as a drug.
- United KingdomUnapprovedAvailable OTC as a supplement; no MHRA drug approval.
Classified as a dietary supplement in the United States (not FDA-approved as a drug). Not approved as a pharmaceutical in the EU or UK. Research use in various jurisdictions. L-Carnosine supplements are commercially available OTC worldwide.
Evidence & Sources
- Journal ArticleModerateBrosnan ME, Brosnan JT2020-01-01T00:00:00.000000Z
- Journal ArticleHighSaunders B, et al.2017-01-01T00:00:00.000000Z
- Journal ArticleModerateCesak O, et al.2023-01-01T00:00:00.000000Z
- Journal ArticleModerateBoldyrev AA, Aldini G, Derave W2013-01-01T00:00:00.000000Z
- Journal ArticleModerateTrexler ET, et al.2015-01-01T00:00:00.000000Z
- Journal ArticleHighSiafis S, et al.2022-01-01T00:00:00.000000Z
Frequently Asked Questions
How does carnosine improve exercise performance?
Carnosine buffers hydrogen ions that accumulate during high‑intensity effort, helping maintain muscle pH. Supplementing with β‑alanine raises muscle carnosine stores, which modestly improves capacity in short‑duration (0.5‑10 min) tasks and reduces neuromuscular fatigue.
Is carnosine supplementation safe?
In healthy adults, β‑alanine (the precursor) at 4‑6 g daily is considered safe. The most common side effect is a tingling sensation that can be lessened by splitting the dose or using sustained‑release forms. No serious adverse events were reported in the reviewed studies.
Can carnosine help with age‑related muscle loss or cognitive decline?
Narrative reviews report that carnosine supplementation may aid in preventing sarcopenia and preserving cognitive abilities, likely due to its antioxidant and anti‑glycation actions. However, these findings are based on limited clinical data and require further confirmation.
What dose and duration are needed to raise muscle carnosine?
Protocols typically use 4‑6 g of β‑alanine per day for a minimum of 4 weeks. This regimen consistently increases muscle carnosine concentrations and is the basis for most performance‑enhancing studies.
What is Carnosine?
Carnosine (β‑alanine‑L‑histidine) is a naturally occurring dipeptide found in skeletal muscle and brain tissue. It can be taken orally or applied topically as a supplement. In humans it is synthesized from the essential amino acid histidine and the non‑essential β‑alanine, and is studied for its intracellular buffering, antioxidant, anti‑glycation and metal‑chelating properties, as well as for potential benefits in exercise performance and various health conditions.
What is Carnosine used for?
Carnosine is educationally associated with: Exercise performance and muscle buffering, Anti‑glycation, Neuroprotection, Metabolic syndrome / glycemic control, Wound healing and skin anti-aging, Ocular health (cataracts), Antioxidant support, pH buffering in muscle, Anti-aging / cellular protection. Educational only — not medical advice.
How is Carnosine administered?
Recorded routes of administration: Intravenous (investigational), Oral, Topical.
What are the potential side effects of Carnosine?
Reported adverse effects include: Gastrointestinal discomfort, Neurological effects in carnosinemia, Paresthesia / tingling, Hypotension (intravenous). This list is not exhaustive — consult a qualified clinician.
Who should avoid Carnosine?
Recorded contraindications: Severe renal impairment, Known hypersensitivity to carnosine or beta-alanine, Carnosinemia (carnosinase deficiency). Consult a qualified clinician before use.